Transcription factor HOXD13 drives melanoma growth and immune evasion
Melanoma Breakthrough: Targeting HOXD13 to Unlock Immune Response and Halt Tumor Growth Researchers have identified a key molecule, HOXD13, that fuels melanoma growth and simultaneously shields tumors from the body’s natural defenses. This discovery, spearheaded by teams at NYU Langone Health and its Perlmutter Cancer Center, offers a promising new avenue for treatment, potentially combining … Read more